Nevro (NVRO) Q3 Earnings Beat Estimates, 2022 View Revised
Nevros (NVRO) worldwide revenues improved on a year-over-year basis in Q3, partly owing to robust domestic performance....…
5,275€
0,48%
Echtzeit-Aktienkurs Nevro Corp.
Bid:
Ask:
Nachrichten zur Nevro Corp. Aktie
Form 10-Q NEVRO CORP For: Sep 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
The Zacks Analyst Blog Highlights Nevro, Masimo, Abiomed and Glaukos
Nevro, Masimo, Abiomed and Glaukos are part of the Zacks top Analyst Blog....…
Boston Scientific drives rival Nevro lower after remarks on neuromodulation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Nevro (NVRO) Gains Following FDA Approval for Senza HFX iQ
Nevro (NVRO) gets FDA approval for its next-generation SCS system, Senza HFX iQ, for treating chronic back and leg pain....…
Nevro Shares Rise 5%, FDA Approves HFX iQ Spinal Cord Stimulation System
Nevro Shares Rise 5%, FDA Approves HFX iQ Spinal Cord Stimulation System...…
Nevro Announces FDA Approval of HFX iQ™ Spinal Cord Stimulation System to Personalize the Treatment of Chronic Pain
Next Generation Senza® HFX iQ™ is the First and Only SCS System that Uses Artificial Intelligence to Optimize and Maintain…
3 Reasons to Retain Nevro (NVRO) Stock in Your Portfolio
Investors continue to be optimistic about Nevro (NVRO), owing to its strength in the global SCS market....…
Nevro plays down impact from UnitedHealth coverage decision
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Nevro Comments on UnitedHealthcare Medical Coverage Policy Update
REDWOOD CITY, Calif., Oct. 10, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering…
Nevro to Report Third Quarter 2022 Financial Results
Company to Host Conference Call on Wednesday, November 2, 2022 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY,…